CTBP1 and esophageal squamous cell carcinoma: Using a CRISPR-directed gene editing technique, we successfully disabled CtBP1 alleles in paclitaxel-resistant ESCC cells, and observed that CtBP1 KO suppressed oncogenic expression, inhibited proliferation, migration and invasion in ESCC cells, and sensitized them to paclitaxel.